Analyst Rick Bienkowski works at CANTOR FITZGERALD and is covering the the Healthcare sector with 28 price targets and ratings documented since 2021 spanning on 4 stocks. Previously, Rick Bienkowski worked at LEERINK.
Most recent stock forecast was given on BEAM, Beam Therapeutics Inc. at 01-Feb-2023.
Analyst best performing recommendations are on EDIT (EDITAS MEDICINE, INC).
Currently, out of the existing stock ratings of Rick Bienkowski - 2 which are a Hold (14.29%), 12 which are a Buy (85.71%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
41
$8.79 (27.29%)
60
30 days ago
2/3 (66.67%)
$-16.16 (-14.34%)
208
Buy
105
$72.79 (225.99%)
145
3 months 9 days ago
0/2 (0%)
$53.13 (105.25%)
Buy
62
$29.79 (92.49%)
113
4 months 9 days ago
0/6 (0%)
$40.69 (80.30%)
Buy
77
$44.79 (139.06%)
81
4 months 18 days ago
0/6 (0%)
$36.01 (61.76%)
Hold
66
$33.79 (104.91%)
61
5 months 21 days ago
2/3 (66.67%)
$10.88 (26.15%)
4
